PROCAN
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

PROCAN Trademark

Serial Number: 79230282 • Registration: 5635196

PROCAN is a trademark filed by Children's Medical Research Institute on March 22, 2017. The trademark is classified under Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently no longer active.

Owner Contact Info

Children's Medical Research Institute (10 trademarks)

214 Hawkesbury Rd

Entity Type: 99

Trademark Details

Filing Date

March 22, 2017

Registration Date

December 25, 2018

Published for Opposition

October 9, 2018

Cancellation Date

July 11, 2025

Goods & Services

Education services, namely, mentoring, tutoring, classes, seminars, and workshops in the fields of medical, proteomic, molecular and genetic analysis and testing and medical research and development; Training services in the fields of medical, proteomic, molecular and genetic analysis and testing and medical research and development; Publishing of electronic publications; Publishing of books, documents, newsletters, and printed matter in the fields of medical diagnosis, medical treatment, medical, proteomic, molecular and genetic analysis and testing, and medical research and development; Advisory, consultancy, and information services in the fields of education and publishing

Software and computer programs for use in medical, proteomic, molecular and genetic analysis and testing; Computer hardware for use in medical, proteomic, molecular and genetic analysis and testing; Scientific apparatus, namely, mass-spectrometers; Downloadable databases in the fields of medicine, proteomics, molecules and genetics; Electronic publications, both downloadable and recorded on computer media, namely, magazines, journals, newspapers, manuals, and e-books in the fields of medicine, proteomics, molecules and genetics

Printed matter, namely, printed publications, namely, journals, leaflets, pamphlets, booklets, and research reports in the fields of medical research and development services, genetics, molecules and proteomics

Charitable fundraising; Financial services, namely, funding research in the fields of medical research, genetic research, molecular research and proteomic research; Fundraising services, by means of raising funds for scientific research, proteomic research, molecular research, genetic research and medical research; Financial sponsorship of medical research, genetic research, molecular research and proteomic research; Funding of scientific and medical research; Fundraising services by means of organizing special events to support medical research, proteomic research, molecular research and genetic research; Advisory, consultancy, and information services in the fields of fundraising and financial sponsorship for medical research, proteomic research, molecular research and genetic research

Medical services, namely, medical health assessment services; Medical services, namely, genetic, proteomic and molecular screening and testing for medical purposes; Medical services, namely, testing physical tumors; Health care services, namely, medical treatment of cancer, health care diagnosis of diseases services, health assessment services, testing of physical tumors, and genetic, proteomic, and molecular screening and testing; Health screening services in the field of oncology testing, proteomic testing, molecular testing and genetic testing; Health risk assessment surveys; Arranging of medical treatment; Conducting of medical examinations; Genetic testing for medical purposes; Advisory, consultancy and information services in the fields of medicine and healthcare

Research, namely, medical research, proteomic research, molecular research and genetic research; Scientific and technological services, namely, scientific research and analysis in the field of medicine medical diagnosis, medical treatment, proteomics, biology, biotechnology and genetics; Analysis of tissues for medical research; Research laboratories; Biological research; Biotechnology research; Genetic research; Development of testing methods and testing methodologies in the fields of medical research, proteomic research, molecular research and genetic research; Development of test equipment for medical research; Technical research in the fields of medicine, proteomics, biology, biotechnology, and genetics; Database design; Scientific research relating to genetics; Advisory, consultancy, and information services in the fields of medical research, scientific research, proteomic research, molecular research and genetic research

Filing History

CANCELLED SECTION 71
Jul 11, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 25, 2023 REM3
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 28, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 28, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 28, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 28, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 28, 2022 COAR
WITHDRAWAL OF ATTORNEY GRANTED
Jun 22, 2022 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Jun 22, 2022 WOAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 26, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 26, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 26, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 26, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 26, 2022 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 26, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 10, 2019 FICS
FINAL DISPOSITION PROCESSED
Apr 10, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 25, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 25, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 9, 2018 NPUB
PUBLISHED FOR OPPOSITION
Oct 9, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Oct 6, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 19, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 19, 2018 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 19, 2018 NONP
ASSIGNED TO LIE
Sep 4, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 21, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 21, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 21, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 21, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 21, 2018 CNEA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Aug 18, 2018 GPRN
PRIORITY ACTION E-MAILED
Aug 18, 2018 GPRA
PRIORITY ACTION WRITTEN
Aug 18, 2018 CPRA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 28, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 27, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 27, 2018 TROA
REFUSAL PROCESSED BY IB
May 12, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 23, 2018 RFCS
REFUSAL PROCESSED BY MPU
Apr 23, 2018 RFRR
APPLICATION FILING RECEIPT MAILED
Apr 20, 2018 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 19, 2018 RFCR
NON-FINAL ACTION WRITTEN
Apr 18, 2018 CNRT
ASSIGNED TO EXAMINER
Apr 16, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 16, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 12, 2018 REPR